Author: Tom Wilemon
Vanderbilt Health Pleasant View now open
Sep. 30, 2022—The new Vanderbilt Health Pleasant View outpatient clinic offers greater convenience to primary care and specialized medical services for patients in Cheatham, Montgomery and Robertson counties.
Vanderbilt lauded for pancreatic cancer, pancreatitis care
Sep. 29, 2022—Vanderbilt has been recognized as a National Pancreas Foundation Center of Excellence.
Lung cancer detection program lands grant renewal
Sep. 15, 2022—The National Cancer Institute has renewed funding for the Early Detection Research Network Lung Cancer Clinical Validation Center at Vanderbilt- Ingram Cancer Center.
Patients had ‘significant and clinically meaningful improvement’ in survival in fruquintinib clinical trial
Sep. 13, 2022—Patients with metastatic colorectal cancer who had not responded to other treatments had “significant and clinically meaningful improvement” in overall survival when treated with the oral targeted therapy fruquintinib.
Grant supports research to study gastric cancer origins
Sep. 1, 2022—Vanderbilt researchers have received $5 million in funding from a new initiative by the National Cancer Institute that aims to define how gastric and gastroesophageal junction adenocarcinomas form and evolve at the cellular level.
Chic Aweareness ovarian cancer fundraiser moves online
Sep. 1, 2022—Chic Awearness, a fundraiser for ovarian cancer research at Vanderbilt-Ingram Cancer Center (VICC), is an online event this year from now throughout September with an in-store shopping opportunity to close out the month called Chic Week.
Abramson, Eng, Johnson named to new VICC roles
Aug. 18, 2022—Three physician researchers at Vanderbilt-Ingram Cancer Center are assuming additional leadership roles.
Trial for colorectal cancer drug reaches primary endpoint
Aug. 17, 2022—A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration has met its primary endpoint of overall survival in a phase 3 clinical trial.
Couple’s gift helps support immunotherapy research
Aug. 11, 2022—Luke and Susan Simons have endowed a new directorship that will support research so that more people can benefit from immunotherapies.
Study that investigated whether three smoking cessation drugs could reduce alcohol intake yields unexpected finding
Aug. 5, 2022—A Vanderbilt study of three proven smoking cessation treatments suggests these medications could play an important role to reduce alcohol use and smoking at the same time.
Study reveals need for matching targeted therapies with EGFR subtypes
Jul. 28, 2022—A Vanderbilt study suggests that clinicians should take a deeper dive into distinguishing EGFR mutations when prescribing targeted therapies for non-small-cell lung cancers.
Holowatyj named chair of scientific advisory board for ACPMP Research Foundation
Jul. 15, 2022—Vanderbilt's Andreana Holowatyj, PhD, MSCI, has been named the inaugural chair of the scientific advisory board for the Appendix Cancer Pseudomyxoma Peritonei Research Foundation.
